Cohance Lifesciences Ltd.

NSE: COHANCE | BSE: 543064 | ISIN: INE03QK01018 | Industry: Pharmaceuticals
| Expensive Performer
438.3000 -11.45 (-2.55%)
NSE Jul 14, 2026 11:49 AM
Volume: 158.1K
 

438.30
-2.55%
Geojit BNP Paribas
The formulation business has registered a de-growth of 16% owing to the general slowness in the segment. With a strong order book and customer base in the CDMO segment , the company is poised to sustain its growth momentum in the long term....
Cohance Lifesciences.. has an average target of 490.50 from 2 brokers.
More from Cohance Lifesciences Ltd.
Recommended